Unit 7 lands Shire, Bayer accounts

Share this article:
Omnicom Group relationship marketing agency Unit 7 has picked up new accounts from two pharma clients, the firm's CEO Loreen Babcock told MM&M.

In July, it was named consumer agency for Shire's Daytrana attention deficit disorder patch, approved by the FDA in April and made available in pharmacies in late June. The firm will also do advertising and relationship marketing work for the launch of another undisclosed Shire brand, according to Babcock.

Unit 7 has also been awarded a global brand position and launch assignment from Bayer's diagnostics division, expected to appear in 2007.

Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

More in News

New lipid agents are high on potency, low on doc awareness

New lipid agents are high on potency, low ...

The new PCSK9 class of cholesterol-lowering antibodies continues to look promising, but many doctors—particularly PCPs—have never even heard of the experimental drugs.

Novartis may have game-changing drug

Novartis may have game-changing drug

Key opinion leaders indicate they are ready to embrace Novartis's experimental heart failure medication LCZ696. Such a move could upend heart failure treatment protocols.

Five things for pharma marketers to know: Tuesday, September 2

Five things for pharma marketers to know: Tuesday, ...

Sanofi and Regeneron unveil Phase-III results of their PCSK9; Merck will present data on its anti-PD-1 at the end of this month; WSJ op/ed suggests US should lead fight against ...